Katsuyoshi Matsuoka

Professor

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Katsuyoshi Matsuoka is affiliated with Toho Daigaku Iryo Center Sakura Byoin in Japan. His research primarily focuses on inflammatory bowel disease, particularly ulcerative colitis, exploring aspects such as treatment efficacy, patient profiling, and the impact of external factors like the COVID-19 pandemic on patient behavior and anxiety. Recent works include studies on advanced therapies, clinical characteristics of difficult-to-treat cases, and the safety and efficacy of new therapeutic agents.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (10)

Kyeong Ok Kim

Professor

Yeungnam University School of Medicine and College of Medicine

SOUTH KOREA

View details

Mamoru Watanabe

JAPAN

View details

Taku Kobayashi

Kitasato University

JAPAN

View details

Masayuki Saruta

Chairman and Professor

Jikei University School of Medicine

JAPAN

View details

Ayako Shoji

University of Tokyo

JAPAN

View details

Kenji Watanabe

University of Toyama

JAPAN

View details

HONG SUB LEE

Associate Professor

Inje University Ilsan Paik Hospital

SOUTH KOREA

View details

Shinichiro Shinzaki

Professor and Chair

Hyogo medical university

JAPAN

View details

Toshifumi Hibi

JAPAN

View details

SUBUM PARK

Pusan National University Yangsan Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katsuyoshi Matsuoka

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)

Persistence of advanced therapies in patients with inflammatory bowel disease: retrospective cohort study using a large healthcare claims database in Japan

Post Hoc Analysis of Anxiety and Behavioral Changes in Japanese Patients With Inflammatory Bowel Disease due to the COVID‐19 Pandemic: Relationship Between Municipal Population at the Place of Residence and Anxiety

Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database

Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study

Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies

Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme

Efficacy and Safety of Etrasimod in Patients with Ulcerative Colitis in Japan: Data from the Phase 3 ELEVATE UC 12 and ELEVATE UC 40 JAPAN Trials

Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study

Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study

Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial

Vaccination in patients with inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)

Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study

Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study

Author Correction: Etrasimod for ulcerative colitis: evaluating phase III results

Etrasimod for ulcerative colitis: evaluating phase III results

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis

Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open

Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study

Collaborators (10)

Kyeong Ok Kim

Mamoru Watanabe

Taku Kobayashi

Masayuki Saruta

Ayako Shoji

Kenji Watanabe

HONG SUB LEE

Shinichiro Shinzaki

Toshifumi Hibi

SUBUM PARK

Make your next move.